Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes

Pauline Girard(Centre National de la Recherche Scientifique), Caroline Aspord(GenVec)
Clinical & Translational Immunology
January 1, 2021
Cited by 11


Related Papers